C
Cynthia Aranow
Researcher at The Feinstein Institute for Medical Research
Publications - 186
Citations - 16685
Cynthia Aranow is an academic researcher from The Feinstein Institute for Medical Research. The author has contributed to research in topics: Lupus erythematosus & Systemic lupus erythematosus. The author has an hindex of 51, co-authored 163 publications receiving 13337 citations. Previous affiliations of Cynthia Aranow include NewYork–Presbyterian Hospital & SUNY Downstate Medical Center.
Papers
More filters
Journal ArticleDOI
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.
Michelle Petri,Ana Maria Orbai,Graciela S. Alarcón,Caroline Gordon,Joan T. Merrill,Paul R. Fortin,Ian N. Bruce,David A. Isenberg,Daniel J. Wallace,Ola Nived,Gunnar Sturfelt,Rosalind Ramsey-Goldman,Sang Cheol Bae,John G. Hanly,Jorge Sanchez-Guerrero,Ann E. Clarke,Cynthia Aranow,Susan Manzi,Murray B. Urowitz,Dafna D. Gladman,Kenneth C. Kalunian,Melissa Costner,Victoria P. Werth,Asad Zoma,Sasha Bernatsky,Guillermo Ruiz-Irastorza,Munther A. Khamashta,Søren Jacobsen,Jill P. Buyon,Peter J. Maddison,Mary Anne Dooley,Ronald F van Vollenhoven,Ellen M. Ginzler,Thomas Stoll,Christine A. Peschken,Joseph L. Jorizzo,Jeffrey P. Callen,S. Sam Lim,Barri J. Fessler,Murat Inanc,Diane L. Kamen,Anisur Rahman,Kristjan Steinsson,Andrew G. Franks,Lisa Sigler,Suhail Hameed,Hong Fang,Ngoc Minh Pham,Robin L. Brey,Michael H. Weisman,Gerald McGwin,Laurence S. Magder +51 more
TL;DR: The Systemic Lupus International Collaborating Clinics (SLICC) group revised and validated the American College of Rheumatology (ACR) systemic lupus erythematosus (SLE) classification criteria in order to improve clinical relevance, meet stringent methodology requirements, and incorporate new knowledge regarding the immunology of SLE.
Journal ArticleDOI
Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis
Ellen M. Ginzler,Mary Anne Dooley,Cynthia Aranow,Mimi Y. Kim,Jill P. Buyon,Joan T. Merrill,Michelle Petri,Gary S. Gilkeson,Daniel J. Wallace,Michael H. Weisman,Gerald B. Appel +10 more
TL;DR: In this 24-week randomized, open-label, noninferiority trial, mycophenolate mofetil was more effective than intravenous cyclophosphamide in inducing remission of lupus nephritis and had a more favorable safety profile.
Journal ArticleDOI
Mortality in systemic lupus erythematosus.
Sasha Bernatsky,J. F. Boivin,Lawrence Joseph,S. Manzi,Ellen M. Ginzler,Dafna D. Gladman,Murray B. Urowitz,Paul R. Fortin,M. Petri,Susan G. Barr,Caroline Gordon,Sang Cheol Bae,David A. Isenberg,Asad Zoma,Cynthia Aranow,Mary Anne Dooley,Ola Nived,Gunnar Sturfelt,Kristjan Steinsson,Graciela S. Alarcón,J L Senécal,Michel Zummer,John G. Hanly,Stephanie Ensworth,Janet E. Pope,Steven M. Edworthy,Anisur Rahman,J Sibley,Hani El-Gabalawy,Timothy McCarthy,Y. St. Pierre,Ann E. Clarke,Rosalind Ramsey-Goldman +32 more
TL;DR: The Lupus Survival Study Group data are reviewed and particularly the data from the State University of New York Health Science Center at Brooklyn, NY is reviewed.
Derivation and Validation of Systemic Lupus International Collaborating Clinics Classification Criteria for Systemic Lupus Erythematosus
M. Petri,A-M Orbai,Graciela S. Alarcón,Caroline Gordon,Joan T. Merrill,PR Fortin,IN Bruce,David A. Isenberg,Daniel J. Wallace,O Nived,Gunnar Sturfelt,Rosalind Ramsey-Goldman,S-C Bae,JG Hanly,Jorge Sánchez-Guerrero,Aileen Clarke,Cynthia Aranow,Susan Manzi,MB Urowitz,Dafna D. Gladman,KC Kalunian,Melissa I. Costner,H Fang,Laurence S. Magder +23 more
TL;DR: The Systemic Lupus International Collaborating Clinics (SLICC) group revised and validated the American College of Rheumatology (ACR) systemic lupus erythematosus (SLE) classification criteria in order to improve clinical relevance, meet stringent methodology requirements, and incorporate new knowledge regarding the immunology of SLE as mentioned in this paper.
Journal ArticleDOI
Vitamin D and the immune system.
TL;DR: As immune cells in autoimmune diseases are responsive to the ameliorative effects of vitamin D, the beneficial effects of supplementing vitamin D-deficient individuals with autoimmune disease may extend beyond the effects on bone and calcium homeostasis.